Efficacy of SNX-1012 in the Treatment of Oral Mucositis

NCT00385515 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

81

Enrollment

INDUSTRY

Sponsor class

Conditions

Stomatitis
Oral Mucositis

Interventions

DRUG: SNX-1012 (meclocycline sulfosalicylate)
DRUG: placebo

Sponsor

Mucosal Therapeutics